Liminal BioSciences Inc.

LMNL · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income$1$12-$119-$207
Dep. & Amort.$1$4$8$10
Deferred Tax$0$0$17$0
Stock-Based Comp.$2$4$6$22
Change in WC-$0$1$1-$14
Other Non-Cash-$36-$122$11$90
Operating Cash Flow-$32-$100-$76-$99
Investing Activities
PP&E Inv.-$0-$0-$2-$4
Net Acquisitions$0$173$5$44
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4-$2-$0-$3
Investing Cash Flow$4$171$2$36
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$40$119
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$45-$8$57$118
Financing Cash Flow-$45-$8$57$118
Forex Effect$2$1-$0-$1
Net Chg. in Cash-$71$63-$16$54
Supplemental Information
Beg. Cash$108$45$61$7
End Cash$37$108$45$61
Free Cash Flow-$32-$100-$78-$104